» Articles » PMID: 24008154

Presence of Anxiety and Depression in Patients with Bronchiectasis Unrelated to Cystic Fibrosis

Overview
Specialty Pulmonary Medicine
Date 2013 Sep 7
PMID 24008154
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Patients with chronic bronchiectasis (BQ) may suffer from psychological disorders. The objective of this study was to assess the presence of anxiety and depression in patients from a specialised BQ Unit, using validated questionnaires.

Patients And Methods: We included patients consecutively diagnosed with BQ (unrelated to cystic fibrosis) by high resolution computed tomography in the study. Patients were clinically stable in the previous three weeks and voluntarily completed the Beck Depression Inventory, State-Trait Anxiety Inventory and St. George's Respiratory Questionnaire, after signing the informed consent. They were classified according to their scores on the psychological screening questionnaires, and their results were compared with the clinical, radiological and functional parameters and Quality of Life.

Results: Seventy patients were included, 48 women and 22 men, with a mean age of 64.19years. Thirty-four percent (34%) of patients showed symptoms of depression, and around 55% had scores above the 50th percentile in trait and state anxiety. The amount of sputum was associated with trait anxiety. Bacterial colonization was related to anxiety (trait and state), especially Pseudomonas aeruginosa colonization. Female patients showed a higher risk of depression. There was no relationship between the Quality of Life scores and the established classifications of anxiety and depression.

Conclusions: A high percentage of patients with BQ presented anxiety (trait and state) and depression. The daily sputum production and bacterial colonization (especially with P. aeruginosa) were the variables most related to anxiety; depression was more common in women. We believe that the presence of psychological disorders should be evaluated, especially in patients with this profile.

Citing Articles

The prevalence and implications of depression and anxiety in patients with bronchiectasis: a systematic review and meta-analysis.

Chang M, Kim H, Lee J ERJ Open Res. 2024; 10(6).

PMID: 39655172 PMC: 11626616. DOI: 10.1183/23120541.00248-2024.


Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study.

Calabrese C, Nolasco S, Annunziata A, Sola A, Imitazione P, Campisi R J Clin Med. 2024; 13(20).

PMID: 39458096 PMC: 11508749. DOI: 10.3390/jcm13206146.


The prevalence of anxiety and depression in bronchiectasis patients and their association with disease severity: a cross-sectional study.

Al Oweidat K, Marie D, Toubasi A, Jaber D, Ahmed K, Abu Alragheb B Sci Rep. 2023; 13(1):20886.

PMID: 38017245 PMC: 10684858. DOI: 10.1038/s41598-023-48276-1.


Multimorbidity in bronchiectasis: a systematic scoping review.

Marsland I, Sobala R, Soyza A, Witham M ERJ Open Res. 2023; 9(1).

PMID: 36687362 PMC: 9841316. DOI: 10.1183/23120541.00296-2022.


Barriers and facilitators of physical activity in children with bronchiectasis: Perspectives from children and parents.

Jones T, Baque E, OGrady K, Goyal V, Chang A, Trost S Front Pediatr. 2022; 10:974363.

PMID: 36275072 PMC: 9579271. DOI: 10.3389/fped.2022.974363.